Rezultati pretraživanja
  1. prije 9 sati

    A brief history of human disease genetics | Nature

  2. prije 23 sata

    With hopes of creating a model to tackle & elevate the , the Chan-Zuckerberg Initiative announced they will grant $450,000 to 30 groups & provide training & resources

  3. 4. velj

    Epidemiological reports on centronuclear provide limited incidence and prevalence data. A landmark article now proposes a model to obtain estimated patient numbers by age, causative gene, severity and geographic region. Learn More:

  4. 4. velj

    While I applaud the Chan Zuckerberg Initiative () in funding 30 patient groups, aiming to build a model for tackling , why was Disease not included? It’s one of the most prevalent but also least funded rare? Help us

  5. 4. velj
    Prikaži ovu nit
  6. 4. velj

    "The idea is to rethink the traditional process by which patient groups fund research..." - Great initiative from to fund and help empower patient groups to be involved in driving research and therapy development for

  7. 3. velj

    “If we can work with these groups to figure out the model — then anyone can do this.” - on ’s efforts to build a model for patient-led groups to make progress on . Read more in

  8. 3. velj
  9. 2. velj

    We are keeping love and hope alive. For Madden and the other children and their families affected by this disease it is what keeps us going.

  10. 2. velj

    ONE OF A KIND What do you do if your child has a condition that is new to science?

  11. 1. velj

    & patients avoid it for fear of saddling their partner w/ debt if they pass away. In sickness and in health, but not in debt: Young Americans avoid 'I do' until student loans are paid off

  12. 1. velj

    Huntington’s disease: I’m taking a test that will reveal my future.

  13. 31. sij

    Phenotype of Saul-Wilson syndrome is remarkably uniform

  14. 31. sij

    David is the only person in the UK with the , occipital horn syndrome. He discusses his experience of having an invisible illness and his hopes for the future in

  15. 30. sij
  16. 30. sij

    Development in the treatment of neurological disorders advances in the form of antisense drugs, a genetic therapy that is able to raise or lower protein levels.

  17. 30. sij
  18. 29. sij

    Pharmaceutical companies have to charge enough to earn back their development costs. Because rare diseases affect less than 200,000 people, that price could be incredibly high.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.